IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v18y2021i8p3880-d531885.html
   My bibliography  Save this article

Neuroenhancement in French and Romanian University Students, Motivations and Associated Factors

Author

Listed:
  • Irina Brumboiu

    (Cluj-Napoca Unit—The Net-Work of International Francophone Clinical Epidemiology, Iuliu Hatieganu University of Medicine and Pharmacy, 400000 Cluj-Napoca, Romania)

  • Alessandro Porrovecchio

    (Univ. Littoral Côte d’Opale, Univ. Lille Artois ULR 7369—URePSSS—Unité de Recherche Pluridiscipli-Naire Sport Santé Société, F-59375 Dunkerque, France)

  • Thierry Peze

    (Univ. Littoral Côte d’Opale, Univ. Lille Artois ULR 7369—URePSSS—Unité de Recherche Pluridiscipli-Naire Sport Santé Société, F-59375 Dunkerque, France)

  • Remy Hurdiel

    (Univ. Littoral Côte d’Opale, Univ. Lille Artois ULR 7369—URePSSS—Unité de Recherche Pluridiscipli-Naire Sport Santé Société, F-59375 Dunkerque, France)

  • Irina Cazacu

    (Cluj-Napoca Unit—The Net-Work of International Francophone Clinical Epidemiology, Iuliu Hatieganu University of Medicine and Pharmacy, 400000 Cluj-Napoca, Romania)

  • Cristina Mogosan

    (Cluj-Napoca Unit—The Net-Work of International Francophone Clinical Epidemiology, Iuliu Hatieganu University of Medicine and Pharmacy, 400000 Cluj-Napoca, Romania)

  • Joel Ladner

    (Clinical Investigation Center 1404 and INSERM 1073, Rouen University Hospital and Rouen Normandie University, 76000 Rouen, France)

  • Marie-Pierre Tavolacci

    (Department of Epidemiology and Health Promotion and INSERM 1073, Rouen University Hospital and Rouen Normandie University, 76000 Rouen, France)

Abstract

This cross-sectional study aimed to determine the use of neuroenhancers, the motivations and factors associated with their use in French and Romanian university students. Students from two universities in France (Rouen and Opal Coast University) and one in Romania (Cluj-Napoca) were asked to complete a self-administered anonymous questionnaire, either online or on paper, about the use of three different categories of substance: Prescription drugs (methylphenidate, modafinil, and beta-blockers), drugs of abuse (alcohol, cannabis, cocaine, and amphetamines), and soft enhancers (coffee, vitamins, caffeine tablets, and energy drinks). In total, 1110 students were included: The users were 2.2% for prescription drugs, 4.3% for drugs of abuse, and 55.0% for soft enhancers. Students used neuroenhancement to stay awake for study (69.3%), to improve concentration (55.5%), to decrease stress (40.9%), and to improve memory (39.6%). Neuroenhancement was considered to meet expectations by 74.4% of users. The factors associated with the use of drugs of abuse were frequent binge drinking (Adjusted Odds Ratio—AOR: 6.49 [95% CI: 2.53–16.6]), smoking (AOR: 5.50 [95% CI: 2.98–10.14]), having a student job (AOR: 2.42 [95% CI 1.13–5.17]), and being male (AOR: 2.23 [95% CI:1.21–4.11]). No significant associations with eating disorders were detected for any of the three categories of substances. University students reported neuroenhancement with prescription drugs, drugs of abuse, and mainly soft enhancers. These substances were used mainly to increase the waking hours. Educational programs in universities seem to be required in order to increase student awareness of the problems caused by neuroenhancements, and to decrease the associated risks by changing students’ attitudes and beliefs.

Suggested Citation

  • Irina Brumboiu & Alessandro Porrovecchio & Thierry Peze & Remy Hurdiel & Irina Cazacu & Cristina Mogosan & Joel Ladner & Marie-Pierre Tavolacci, 2021. "Neuroenhancement in French and Romanian University Students, Motivations and Associated Factors," IJERPH, MDPI, vol. 18(8), pages 1-13, April.
    • Handle: RePEc:gam:jijerp:v:18:y:2021:i:8:p:3880-:d:531885
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/18/8/3880/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/18/8/3880/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Brendan Maher, 2008. "Poll results: look who's doping," Nature, Nature, vol. 452(7188), pages 674-675, April.
    2. Nora D. Volkow & James M. Swanson, 2008. "The action of enhancers can lead to addiction," Nature, Nature, vol. 451(7178), pages 520-520, January.
    3. Henry Greely & Barbara Sahakian & John Harris & Ronald C. Kessler & Michael Gazzaniga & Philip Campbell & Martha J. Farah, 2008. "Towards responsible use of cognitive-enhancing drugs by the healthy," Nature, Nature, vol. 456(7223), pages 702-705, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Paul A. Schulte & Ivo Iavicoli & Luca Fontana & Stavroula Leka & Maureen F. Dollard & Acran Salmen-Navarro & Fernanda J. Salles & Kelly P. K. Olympio & Roberto Lucchini & Marilyn Fingerhut & Francesco, 2022. "Occupational Safety and Health Staging Framework for Decent Work," IJERPH, MDPI, vol. 19(17), pages 1-28, August.
    2. Petersen, Alexander M. & Penner, Orion, 2020. "Renormalizing individual performance metrics for cultural heritage management of sports records," Chaos, Solitons & Fractals, Elsevier, vol. 136(C).
    3. Huttunen, Henri & Sivula, Oskari, 2023. "Moral adherence enhancement and the case of long-distance space missions," Technology in Society, Elsevier, vol. 74(C).
    4. Williams, Simon J. & Coveney, Catherine M. & Gabe, Jonathan, 2013. "Medicalisation or customisation? Sleep, enterprise and enhancement in the 24/7 society," Social Science & Medicine, Elsevier, vol. 79(C), pages 40-47.
    5. Thomas, Felicity & Depledge, Michael, 2015. "Medicine ‘misuse’: Implications for health and environmental sustainability," Social Science & Medicine, Elsevier, vol. 143(C), pages 81-87.
    6. Vrecko, Scott, 2015. "Everyday drug diversions: A qualitative study of the illicit exchange and non-medical use of prescription stimulants on a university campus," Social Science & Medicine, Elsevier, vol. 131(C), pages 297-304.
    7. Sebastian Sattler & Olaf von dem Knesebeck, 2022. "Effort–Reward Imbalance at Work and Prescription Drug Misuse—Prospective Evidence from Germany," IJERPH, MDPI, vol. 19(13), pages 1-12, June.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:18:y:2021:i:8:p:3880-:d:531885. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.